fluorouracil has been researched along with gambogic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Y; Guo, Q; Li, X; Liu, X; Sun, H; Wang, X; Wang, Y; Yang, Y; You, Q; Zeng, S; Zhang, S; Zhang, X; Zhao, L | 1 |
Bian, J; Hu, M; Jiang, F; Li, X; Sun, H; Wu, Y; Yang, L; You, Q; Zhang, X | 1 |
Liu, Y; Xu, Z; Zhao, SJ | 1 |
Guo, QL; Liu, W; Lu, N; Nei, FF; Qi, Q; Rong, JJ; Wang, J; Yang, Y; You, QD; Zhao, Q | 1 |
Li, XL; Liu, BR; Qian, XP; Wang, TT; Wei, J; Yu, LX; Zou, ZY | 1 |
Chen, J; Huang, L; Iwamoto, A; Li, W; Lin, M; Liu, H; Lu, B; Rutnam, ZJ; Wang, Z; Wen, C; Yang, X | 1 |
1 review(s) available for fluorouracil and gambogic acid
Article | Year |
---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
5 other study(ies) available for fluorouracil and gambogic acid
Article | Year |
---|---|
Garcinia xanthones as orally active antitumor agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Garcinia; Humans; Hydrogen-Ion Concentration; Male; Membranes, Artificial; Mice; Neoplasm Transplantation; Permeability; Solubility; Structure-Activity Relationship; Transplantation, Heterologous; Xanthones | 2013 |
Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Body Weight; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Drug Screening Assays, Antitumor; Garcinia; Humans; Mice; Structure-Activity Relationship; Transplantation, Heterologous; Xanthones | 2015 |
Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
Topics: Animals; Annexin A5; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Xanthones | 2009 |
Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Docetaxel; Drug Synergism; Fluorouracil; Gene Expression; Humans; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Xanthones | 2012 |
Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice; Xanthones; Xenograft Model Antitumor Assays | 2015 |